Sponsor Dossier
LumaCina
Sponsor Dossier for LumaCina. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: Bridgewest
- Brand: HYDROGEN
- Brand: Leucovorin
- Brand: LumaCina
- Brand: LUMACINA-MORPHINE
- Brand: morphine
- Brand: POVIDONE-IODINE
- Brand: TRANEXAMIC
About
LumaCina is an Australian Private Company with ABN 48690795629, registered in Western Australia and currently active.
Portfolio
LumaCina has 8 brands on the ARTG, of which 4 are indexable and 3 carry a Product Information document. 1 brand is PBS-listed, 0 have a PBAC outcome on record, and 1 has an AusPAR on record. Notable brands include Bridgewest, HYDROGEN, Leucovorin, LumaCina, LUMACINA-MORPHINE, morphine, POVIDONE-IODINE, TRANEXAMIC.
Therapeutic focus
— Infectious Disease: 2 brands — Other: 2 brands — Pain Management: 2 brands — Oncology: 1 brand — Haematology: 1 brand
PBS footprint
1 brand is PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest AusPAR is 2010-12-15, across 1 brand with an AusPAR on record.